Acasti Pharma, Inc.

Historical 13F Holders

Reported Value, Excluding Options

Total Filings

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for 00430K865 since 12/18/2024, largest first.

Filer	% of Class	Shares	Form	Filed
ADAR1 Capital Management, LLC 13G/A	9.9%	1,534,254	13G/A	11/14/2025 Event 9/30/2025
ADAR1 Capital Management, LLC	9.9%	1,529,200
ADAR1 Capital Management GP, LLC	9.9%	1,534,254
Daniel Schneeberger	9.9%	1,529,200

Period	Filings	Shares, Excl. Options	Value, Excl. Options	Options Value
2025 Q4	1	20.0	$0	$0
2024 Q3	13	1.16 M	$3.48 M	$0
2024 Q2	15	2.15 M	$6.31 M	$0
2024 Q1	13	1.27 M	$4.35 M	$0
2023 Q4	11	573 k	$1.66 M	$0
2023 Q3	13	558 k	$1.55 M	$0